NBIX (Neurocrine Biosciences Inc) Prakiraan volume dodolan

Logo grafis Neurocrine (NBIX)

Neurocrine Biosciences (NBIX) relies on the dominance of Ingrezza in dyskinesia therapy and the success of new molecules. Sales of this drug are accelerating capital inflows, confirming the company's potential sales volume, where the current value equals 5.10. However, geopolitical tensions are hindering international research and the procurement of chemical raw materials, creating logistics risks for neurobiological products.

Prakiraan pendapatan perusahaan: Neurocrine Corp (NBIX) kanggo 04.07.2022 - 18.11.2026

Rincian metrik keuangan lan pasar Neurocrine Biosciences Inc (NBIX)

Analisis umum perusahaan:Neurocrine
Sampel barang Neurocrine

The scale of Neurocrine Biosciences (NBIX) operations amidst fierce competition with pharma behemoths makes the company's projected sales level a key indicator of commercial viability. This metric aggregates the market value of future revenues, allowing investors to identify hidden anomalies in strategy execution through the analysis of daily price action and assess the actual capital density ensuring business resilience in a high-risk environment.

Pesaing utama

Volume dodolan mangsa ngarep perusahaan BIIB (Biogen)|Prakiraan pendapatan perusahaan RGC (Regencell Bioscience Ltd)|Axsome Therapeutics, Inc. - Volume dodolan mangsa ngarep perusahaan|ACAD (ACADIA Pharmaceuticals Inc) - Pendapatan sing dikarepake perusahaan|Xenon Corp - Prakiraan volume dodolan|Pendapatan mangsa ngarep perusahaan VKTX (Viking Therapeutics)|Supernus Pharmaceuticals (SUPN) - Prakiraan pendapatan perusahaan|Pendapatan sing dikarepake perusahaan CPRX (Catalyst Pharmaceuticals, Inc.)|Prakiraan pendapatan perusahaan Denali Therapeutics Inc|Volume dodolan sing dikarepake perusahaan Harmony Corp HRMY|Prakiraan volume dodolan BHVN|Volume dodolan mangsa ngarep perusahaan Amylyx Pharmaceuticals AMLX|Prakiraan volume dodolan TRVI (Trevi Corp)|Dodolan mangsa ngarep perusahaan Praxis Precision Medicines, Inc. (PRAX)|Anavex Life Sciences Corp - Prakiraan volume dodolan|CeriBell Corp (CBLL) - Volume dodolan mangsa ngarep perusahaan|Prothena Corp (PRTA) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Alector Inc. (ALEC)|Volume dodolan mangsa ngarep perusahaan ANNX|omeros.com (OMER) - Dodolan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan Neurogene Inc. (NGNE)|ACIU (AC Immune Inc) - Pendapatan mangsa ngarep perusahaan|Prakiraan volume dodolan VYGR (voyagertherapeutics.com)|Dodolan mangsa ngarep perusahaan Neumora Therapeutics (NMRA)|SCLX - Prakiraan pendapatan perusahaan|Prakiraan dodolan perusahaan Tevogen Bio Holdings Inc. (TVGN)|Alpha Cognition (ACOG) - Prakiraan pendapatan perusahaan|CGTX - Dodolan mangsa ngarep perusahaan|IKT (inhibikase.com) - Prakiraan volume dodolan|cassavasciences.com (SAVA) - Dodolan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan ASRT (Assertio Therapeutics)|Dodolan mangsa ngarep perusahaan Coya Therapeutics|Vistagen - Volume dodolan mangsa ngarep perusahaan|ovidrx.com (OVID) - Volume dodolan sing dikarepake perusahaan|Acumen Pharmaceuticals - Prakiraan volume dodolan|Volume dodolan sing dikarepake perusahaan cervomed.com|ATHE: Prakiraan volume dodolan|Clene Inc - Pendapatan mangsa ngarep perusahaan|Prakiraan pendapatan perusahaan PepGen|JUNS (Jupiter Neurosciences Inc) - Prakiraan volume pendapatan perusahaan|Volume dodolan mangsa ngarep perusahaan RLMD (Relmada Corp)|annovisbio.com - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan gracetx.com GRCE|AIFF (Firefly Neuroscience, Inc.) - Pendapatan sing dikarepake perusahaan|KLTO - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan NeuroSense Therapeutics Ltd|Reviva Pharmaceuticals (RVPH) - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan MTVA|Volume dodolan mangsa ngarep perusahaan NRXS|Volume dodolan mangsa ngarep perusahaan Helius Medical (HSDT)|Prakiraan volume dodolan PASG|Neuphoria Therapeutics - Prakiraan pendapatan perusahaan|Prakiraan pendapatan perusahaan Minerva Neurosciences, Inc. NERV|Prakiraan volume dodolan Athira Pharma ATHA|ADXN: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Alzamend Neuro|Cyclerion Therapeutics Inc. (CYCN) - Prakiraan pendapatan perusahaan|Volume dodolan sing dikarepake perusahaan Protagenic Therapeutics (PTIX)|KTTA (pasitheaclinics.com) - Prakiraan volume dodolan|Volume dodolan mangsa ngarep perusahaan Cortigent (CRGT)|Prakiraan volume dodolan ATXI|BCLI - Volume dodolan sing dikarepake perusahaan|Prakiraan volume dodolan CARA (Cara Therapeutics, Inc)|Chromocell Therapeutics Corporation (CHRO) - Volume dodolan sing dikarepake perusahaan|ELYM - Prakiraan pendapatan perusahaan|Prakiraan dodolan perusahaan intracellulartherapies.com (ITCI)|Longboard (LBPH) - Prakiraan pendapatan perusahaan|Marinus Pharmaceuticals Inc - Pendapatan mangsa ngarep perusahaan|Volume dodolan mangsa ngarep perusahaan NKGN|NeuroBo - Pendapatan sing dikarepake perusahaan|Prakiraan pendapatan perusahaan Sage Therapeutics, Inc (SAGE)|Volume dodolan mangsa ngarep perusahaan Synaptogenix SNPX|Trevena, Inc. - Volume dodolan mangsa ngarep perusahaan|VIGL: Prakiraan pendapatan perusahaan|WENA: Volume dodolan mangsa ngarep perusahaan|Volume dodolan sing dikarepake perusahaan Cerevel Therapeutics